Chris J. Packard
Glasgow Clinical Research Facility
Tennent Building
38 Church Street
Western Infirmary
UK
Name/email consistency: high
- Early life socioeconomic adversity is associated in adult life with chronic inflammation, carotid atherosclerosis, poorer lung function and decreased cognitive performance: a cross-sectional, population-based study. Packard, C.J., Bezlyak, V., McLean, J.S., Batty, G.D., Ford, I., Burns, H., Cavanagh, J., Deans, K.A., Henderson, M., McGinty, A., Millar, K., Sattar, N., Shiels, P.G., Velupillai, Y.N., Tannahill, C. BMC. Public. Health (2011)
- Optimizing lipid-lowering therapy in the prevention of coronary heart disease. Packard, C.J. Expert. Rev. Clin. Pharmacol (2010)
- Lipoprotein-associated phospholipase A2 as a biomarker of coronary heart disease and a therapeutic target. Packard, C.J. Curr. Opin. Cardiol. (2009)
- Association between apolipoprotein E4 and cognitive decline in elderly adults. Packard, C.J., Westendorp, R.G., Stott, D.J., Caslake, M.J., Murray, H.M., Shepherd, J., Blauw, G.J., Murphy, M.B., Bollen, E.L., Buckley, B.M., Cobbe, S.M., Ford, I., Gaw, A., Hyland, M., Jukema, J.W., Kamper, A.M., Macfarlane, P.W., Jolles, J., Perry, I.J., Sweeney, B.J., Twomey, C. J. Am. Geriatr. Soc (2007)
- A triumvirate of targets in the prevention and treatment paradigm for cardiovascular disease. Packard, C. Atheroscler. Suppl (2006)
- Small dense low-density lipoprotein and its role as an independent predictor of cardiovascular disease. Packard, C.J. Curr. Opin. Lipidol. (2006)
- Plasma lipoproteins and apolipoproteins as predictors of cardiovascular risk and treatment benefit in the PROspective Study of Pravastatin in the Elderly at Risk (PROSPER). Packard, C.J., Ford, I., Robertson, M., Shepherd, J., Blauw, G.J., Murphy, M.B., Bollen, E.L., Buckley, B.M., Cobbe, S.M., Gaw, A., Hyland, M., Jukema, J.W., Kamper, A.M., Macfarlane, P.W., Perry, I.J., Stott, D.J., Sweeney, B.J., Twomey, C., Westendorp, R.G. Circulation (2005)
- Triacylglycerol-rich lipoproteins and the generation of small, dense low-density lipoprotein. Packard, C.J. Biochem. Soc. Trans. (2003)
- Lipoprotein-associated phospholipase A2 as an independent predictor of coronary heart disease. West of Scotland Coronary Prevention Study Group. Packard, C.J., O'Reilly, D.S., Caslake, M.J., McMahon, A.D., Ford, I., Cooney, J., Macphee, C.H., Suckling, K.E., Krishna, M., Wilkinson, F.E., Rumley, A., Lowe, G.D. N. Engl. J. Med. (2000)